| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retina | 33 | 2023 | 421 | 4.900 |
Why?
|
| Synapses | 13 | 2023 | 48 | 1.950 |
Why?
|
| Nerve Tissue Proteins | 12 | 2013 | 151 | 1.730 |
Why?
|
| Neurons | 12 | 2017 | 274 | 1.460 |
Why?
|
| Eye Proteins | 9 | 2023 | 197 | 1.370 |
Why?
|
| Retinal Degeneration | 10 | 2023 | 141 | 1.320 |
Why?
|
| Membrane Proteins | 9 | 2023 | 470 | 1.280 |
Why?
|
| Retinal Cone Photoreceptor Cells | 9 | 2012 | 115 | 1.150 |
Why?
|
| Spinocerebellar Ataxias | 3 | 2023 | 26 | 1.080 |
Why?
|
| Photoreceptor Cells, Vertebrate | 6 | 2020 | 62 | 1.060 |
Why?
|
| Animals | 56 | 2024 | 10082 | 0.960 |
Why?
|
| Mutation | 6 | 2024 | 823 | 0.830 |
Why?
|
| Electroretinography | 13 | 2023 | 173 | 0.830 |
Why?
|
| Mice | 28 | 2024 | 4472 | 0.830 |
Why?
|
| Receptors, Melatonin | 2 | 2013 | 10 | 0.810 |
Why?
|
| Retinal Rod Photoreceptor Cells | 8 | 2014 | 90 | 0.790 |
Why?
|
| Melatonin | 2 | 2013 | 23 | 0.790 |
Why?
|
| Sulfotransferases | 2 | 2012 | 8 | 0.760 |
Why?
|
| Synaptic Transmission | 6 | 2023 | 48 | 0.670 |
Why?
|
| Immunohistochemistry | 19 | 2012 | 455 | 0.660 |
Why?
|
| Visual Pathways | 4 | 2013 | 17 | 0.630 |
Why?
|
| Photoreceptor Cells | 7 | 2002 | 36 | 0.600 |
Why?
|
| Ambystoma | 8 | 2003 | 16 | 0.600 |
Why?
|
| Neural Pathways | 5 | 2013 | 118 | 0.600 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2000 | 22 | 0.590 |
Why?
|
| Membrane Glycoproteins | 5 | 2010 | 143 | 0.560 |
Why?
|
| Retinitis Pigmentosa | 2 | 2023 | 28 | 0.550 |
Why?
|
| Neurotransmitter Agents | 7 | 2013 | 20 | 0.540 |
Why?
|
| Fibroblasts | 3 | 2013 | 151 | 0.510 |
Why?
|
| Rats | 7 | 2023 | 1544 | 0.480 |
Why?
|
| Presynaptic Terminals | 7 | 2012 | 21 | 0.470 |
Why?
|
| Silicone Elastomers | 1 | 2013 | 4 | 0.440 |
Why?
|
| Qa-SNARE Proteins | 2 | 2020 | 7 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 12 | 2022 | 1496 | 0.440 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 16 | 0.430 |
Why?
|
| Cell Differentiation | 4 | 2013 | 398 | 0.420 |
Why?
|
| Cell Movement | 2 | 2013 | 353 | 0.410 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2012 | 3 | 0.400 |
Why?
|
| Xenopus laevis | 1 | 2012 | 49 | 0.390 |
Why?
|
| Xenopus Proteins | 1 | 2012 | 28 | 0.390 |
Why?
|
| Rod Cell Outer Segment | 2 | 2010 | 42 | 0.370 |
Why?
|
| Sodium Channels | 2 | 2008 | 8 | 0.370 |
Why?
|
| Synaptic Vesicles | 4 | 2005 | 17 | 0.360 |
Why?
|
| Morphogenesis | 1 | 2010 | 21 | 0.350 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2010 | 8 | 0.350 |
Why?
|
| Amacrine Cells | 5 | 2010 | 7 | 0.340 |
Why?
|
| Fatty Acids | 3 | 2023 | 202 | 0.330 |
Why?
|
| Nerve Regeneration | 2 | 2002 | 12 | 0.330 |
Why?
|
| Rabbits | 2 | 2007 | 275 | 0.320 |
Why?
|
| Mice, Knockout | 9 | 2023 | 793 | 0.310 |
Why?
|
| Glycine | 4 | 2000 | 31 | 0.280 |
Why?
|
| Retinal Horizontal Cells | 3 | 2013 | 3 | 0.270 |
Why?
|
| Brain | 3 | 2024 | 710 | 0.260 |
Why?
|
| Calcium-Binding Proteins | 2 | 2004 | 60 | 0.260 |
Why?
|
| Endocytosis | 2 | 2011 | 81 | 0.260 |
Why?
|
| Cerebellum | 2 | 2023 | 41 | 0.260 |
Why?
|
| Retinal Ganglion Cells | 5 | 2007 | 26 | 0.240 |
Why?
|
| Oligodendroglia | 1 | 2024 | 13 | 0.230 |
Why?
|
| Myelin Sheath | 1 | 2024 | 25 | 0.230 |
Why?
|
| Protein Isoforms | 5 | 2006 | 118 | 0.230 |
Why?
|
| Vesicular Transport Proteins | 2 | 2004 | 33 | 0.230 |
Why?
|
| Interleukin-6 | 1 | 2005 | 190 | 0.220 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 6 | 2011 | 50 | 0.220 |
Why?
|
| Rats, Transgenic | 2 | 2021 | 12 | 0.220 |
Why?
|
| Goldfish | 3 | 2005 | 4 | 0.220 |
Why?
|
| Amino Acids | 2 | 2003 | 82 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1406 | 0.210 |
Why?
|
| Urodela | 2 | 2003 | 4 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 66 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2013 | 121 | 0.210 |
Why?
|
| In Vitro Techniques | 4 | 2013 | 241 | 0.200 |
Why?
|
| Rhodopsin | 2 | 2020 | 40 | 0.200 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 68 | 0.190 |
Why?
|
| Cells, Cultured | 6 | 2015 | 977 | 0.190 |
Why?
|
| Aspartic Acid | 4 | 2000 | 52 | 0.190 |
Why?
|
| Carrier Proteins | 1 | 2003 | 246 | 0.190 |
Why?
|
| Microscopy, Electron | 5 | 2012 | 94 | 0.190 |
Why?
|
| Immunoblotting | 3 | 2012 | 122 | 0.190 |
Why?
|
| Signal Transduction | 4 | 2023 | 1374 | 0.190 |
Why?
|
| Astrocytes | 1 | 2022 | 73 | 0.190 |
Why?
|
| Blotting, Western | 6 | 2012 | 506 | 0.190 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2021 | 22 | 0.190 |
Why?
|
| Integrins | 1 | 2001 | 27 | 0.180 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2012 | 54 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 49 | 0.180 |
Why?
|
| Tyrosine | 2 | 2012 | 92 | 0.180 |
Why?
|
| Wound Healing | 3 | 2013 | 113 | 0.180 |
Why?
|
| Phenotype | 3 | 2020 | 667 | 0.180 |
Why?
|
| Night Vision | 1 | 2020 | 7 | 0.180 |
Why?
|
| Retinal Detachment | 1 | 2000 | 10 | 0.180 |
Why?
|
| Retinal Photoreceptor Cell Inner Segment | 1 | 2020 | 4 | 0.180 |
Why?
|
| Neuroglia | 3 | 2013 | 30 | 0.170 |
Why?
|
| Hippocampus | 2 | 2022 | 187 | 0.170 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2020 | 18 | 0.170 |
Why?
|
| Gene Expression | 3 | 2013 | 407 | 0.170 |
Why?
|
| Peripherins | 1 | 2020 | 47 | 0.170 |
Why?
|
| Glutamic Acid | 5 | 2004 | 50 | 0.170 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 209 | 0.170 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 18 | 0.170 |
Why?
|
| Apoptosis | 3 | 2013 | 738 | 0.170 |
Why?
|
| Axons | 2 | 2003 | 24 | 0.160 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 490 | 0.160 |
Why?
|
| Dendrites | 3 | 2012 | 16 | 0.150 |
Why?
|
| Nerve Endings | 2 | 2001 | 6 | 0.150 |
Why?
|
| R-SNARE Proteins | 3 | 2003 | 5 | 0.150 |
Why?
|
| Retinal Bipolar Cells | 2 | 2010 | 6 | 0.150 |
Why?
|
| Humans | 11 | 2023 | 27175 | 0.150 |
Why?
|
| Photic Stimulation | 2 | 2008 | 67 | 0.140 |
Why?
|
| Seizures | 1 | 2017 | 46 | 0.140 |
Why?
|
| Vesicular Glutamate Transport Protein 1 | 2 | 2010 | 2 | 0.140 |
Why?
|
| Cycloheptanes | 1 | 2016 | 4 | 0.140 |
Why?
|
| Hypoxia, Brain | 1 | 2016 | 5 | 0.140 |
Why?
|
| Interneurons | 3 | 2003 | 24 | 0.140 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 31 | 0.130 |
Why?
|
| Lizards | 5 | 1993 | 11 | 0.130 |
Why?
|
| Brain Concussion | 1 | 2016 | 43 | 0.130 |
Why?
|
| Piperidines | 1 | 2016 | 45 | 0.130 |
Why?
|
| Blast Injuries | 1 | 2016 | 31 | 0.130 |
Why?
|
| Biomarkers | 3 | 2010 | 736 | 0.130 |
Why?
|
| Male | 8 | 2024 | 13034 | 0.120 |
Why?
|
| Glutamates | 2 | 1992 | 14 | 0.120 |
Why?
|
| Tissue Distribution | 2 | 2007 | 132 | 0.120 |
Why?
|
| Retinal Neurons | 1 | 2015 | 13 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 55 | 0.120 |
Why?
|
| Ependymoglial Cells | 1 | 2015 | 29 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 163 | 0.120 |
Why?
|
| Circadian Rhythm | 2 | 2013 | 76 | 0.110 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 41 | 0.110 |
Why?
|
| Biological Assay | 1 | 2013 | 35 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2013 | 1 | 0.110 |
Why?
|
| Diabetic Retinopathy | 1 | 2015 | 108 | 0.110 |
Why?
|
| Lectins | 1 | 2013 | 12 | 0.110 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 65 | 0.110 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2013 | 18 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2013 | 22 | 0.110 |
Why?
|
| Models, Biological | 2 | 2013 | 448 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2013 | 2 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 188 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 101 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 4 | 1993 | 111 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 99 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 40 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2012 | 23 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2000 | 247 | 0.090 |
Why?
|
| Endosomes | 1 | 2011 | 44 | 0.090 |
Why?
|
| Calcium | 2 | 2010 | 232 | 0.090 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 7 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2011 | 96 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 438 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 131 | 0.090 |
Why?
|
| Female | 6 | 2022 | 14658 | 0.090 |
Why?
|
| Phylogeny | 1 | 2013 | 463 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2011 | 110 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1041 | 0.080 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2007 | 1 | 0.070 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2007 | 1 | 0.070 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2007 | 1 | 0.070 |
Why?
|
| Tetrodotoxin | 1 | 2007 | 12 | 0.070 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2007 | 2 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2007 | 10 | 0.070 |
Why?
|
| Injections | 1 | 2007 | 31 | 0.070 |
Why?
|
| Dark Adaptation | 1 | 2007 | 11 | 0.070 |
Why?
|
| Vitreous Body | 1 | 2007 | 22 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2007 | 50 | 0.070 |
Why?
|
| Arrestin | 3 | 2012 | 11 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 679 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2005 | 7 | 0.070 |
Why?
|
| Synaptotagmins | 2 | 2004 | 4 | 0.070 |
Why?
|
| Synaptotagmin I | 2 | 2004 | 5 | 0.070 |
Why?
|
| Cell Survival | 3 | 2013 | 395 | 0.070 |
Why?
|
| Blindness | 2 | 2005 | 34 | 0.060 |
Why?
|
| Contactins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 4 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2005 | 5 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 130 | 0.060 |
Why?
|
| Rats, Long-Evans | 2 | 2021 | 34 | 0.060 |
Why?
|
| Dynamins | 1 | 2005 | 7 | 0.060 |
Why?
|
| Clathrin | 1 | 2005 | 19 | 0.060 |
Why?
|
| Orbit | 1 | 2005 | 8 | 0.060 |
Why?
|
| Genes, Mitochondrial | 1 | 2024 | 10 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2024 | 13 | 0.060 |
Why?
|
| Thy-1 Antigens | 1 | 2004 | 3 | 0.060 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2004 | 1 | 0.060 |
Why?
|
| SNARE Proteins | 2 | 2020 | 6 | 0.060 |
Why?
|
| Corneal Injuries | 1 | 2004 | 11 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 66 | 0.060 |
Why?
|
| Cornea | 1 | 2004 | 65 | 0.060 |
Why?
|
| Transcription Factors | 3 | 2013 | 514 | 0.060 |
Why?
|
| Nerve Fibers | 1 | 2003 | 53 | 0.050 |
Why?
|
| Purkinje Cells | 1 | 2023 | 7 | 0.050 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2003 | 1 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 7 | 0.050 |
Why?
|
| Calbindin 2 | 1 | 2003 | 3 | 0.050 |
Why?
|
| Silver Staining | 2 | 1993 | 3 | 0.050 |
Why?
|
| Cell Separation | 1 | 2003 | 55 | 0.050 |
Why?
|
| Staining and Labeling | 2 | 1993 | 67 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2003 | 178 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2003 | 72 | 0.050 |
Why?
|
| Autoradiography | 2 | 1992 | 28 | 0.050 |
Why?
|
| Species Specificity | 1 | 2003 | 187 | 0.050 |
Why?
|
| Gliosis | 1 | 2022 | 17 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 88 | 0.050 |
Why?
|
| Serine | 1 | 2022 | 48 | 0.050 |
Why?
|
| Superoxides | 1 | 2022 | 61 | 0.050 |
Why?
|
| Synapsins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Synaptophysin | 1 | 2002 | 3 | 0.050 |
Why?
|
| Protein Kinase C-alpha | 2 | 2013 | 9 | 0.050 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2002 | 4 | 0.050 |
Why?
|
| Pseudopodia | 1 | 2002 | 7 | 0.050 |
Why?
|
| Neurites | 1 | 2002 | 9 | 0.050 |
Why?
|
| Indoles | 1 | 2003 | 98 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 62 | 0.050 |
Why?
|
| Epitopes | 1 | 2003 | 177 | 0.050 |
Why?
|
| Transducin | 2 | 2012 | 13 | 0.050 |
Why?
|
| Motor Disorders | 1 | 2021 | 9 | 0.050 |
Why?
|
| Opsins | 2 | 2011 | 18 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 55 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 200 | 0.050 |
Why?
|
| Integrin alpha2 | 1 | 2001 | 1 | 0.050 |
Why?
|
| Integrin alpha1 | 1 | 2001 | 1 | 0.050 |
Why?
|
| Integrin alpha5 | 1 | 2001 | 1 | 0.050 |
Why?
|
| Integrin alpha6 | 1 | 2001 | 1 | 0.050 |
Why?
|
| Integrin alpha4 | 1 | 2001 | 2 | 0.050 |
Why?
|
| Larva | 1 | 2001 | 28 | 0.050 |
Why?
|
| Integrin alpha3 | 1 | 2001 | 18 | 0.050 |
Why?
|
| Aplysia | 1 | 2000 | 1 | 0.040 |
Why?
|
| Sex Factors | 1 | 2022 | 451 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2001 | 134 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2000 | 35 | 0.040 |
Why?
|
| Antioxidants | 1 | 2022 | 223 | 0.040 |
Why?
|
| Time Factors | 2 | 2002 | 1573 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2000 | 64 | 0.040 |
Why?
|
| Bicuculline | 1 | 2000 | 4 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 2000 | 4 | 0.040 |
Why?
|
| Muscimol | 1 | 2000 | 8 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 2000 | 16 | 0.040 |
Why?
|
| Pyridazines | 1 | 2000 | 7 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 153 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2000 | 62 | 0.040 |
Why?
|
| Cell Count | 2 | 2013 | 85 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 681 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 724 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 299 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 318 | 0.040 |
Why?
|
| Rod Opsins | 2 | 2012 | 14 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 342 | 0.040 |
Why?
|
| Photography | 1 | 1998 | 19 | 0.040 |
Why?
|
| Micromanipulation | 1 | 1998 | 3 | 0.040 |
Why?
|
| Actins | 2 | 2012 | 94 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 482 | 0.040 |
Why?
|
| Macular Degeneration | 1 | 2017 | 79 | 0.030 |
Why?
|
| Receptors, Opioid | 1 | 2016 | 26 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 52 | 0.030 |
Why?
|
| Proteome | 1 | 2016 | 76 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 960 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2013 | 647 | 0.030 |
Why?
|
| Motor Activity | 1 | 2016 | 145 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 538 | 0.030 |
Why?
|
| Mosaicism | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 58 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 15 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2013 | 5 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 42 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 29 | 0.030 |
Why?
|
| Potassium Dichromate | 1 | 1993 | 1 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2013 | 111 | 0.030 |
Why?
|
| Cell Size | 1 | 1993 | 22 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 100 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 74 | 0.030 |
Why?
|
| Chickens | 3 | 2005 | 59 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2013 | 177 | 0.030 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2012 | 5 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 353 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2012 | 27 | 0.020 |
Why?
|
| Monensin | 1 | 2011 | 4 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2011 | 6 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 236 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2012 | 53 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 23 | 0.020 |
Why?
|
| Eye Diseases | 1 | 2012 | 31 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 135 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 627 | 0.020 |
Why?
|
| Sulfates | 1 | 2012 | 86 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 93 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2011 | 33 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 206 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 115 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 39 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 115 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 752 | 0.020 |
Why?
|
| Retinal Pigments | 1 | 1990 | 1 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 165 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2010 | 10 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Biophysics | 1 | 2010 | 14 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2010 | 30 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2010 | 61 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2010 | 34 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 567 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2010 | 22 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 80 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2010 | 68 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2010 | 116 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 291 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 253 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 388 | 0.020 |
Why?
|
| Optic Nerve Injuries | 1 | 2008 | 4 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2008 | 11 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2008 | 70 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 1271 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2005 | 21 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 42 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 21 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 2005 | 14 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2005 | 44 | 0.010 |
Why?
|
| Syntaxin 1 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Exocytosis | 1 | 2004 | 13 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2004 | 32 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 38 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2004 | 53 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 324 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 408 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 636 | 0.010 |
Why?
|
| Ganglia, Invertebrate | 1 | 2000 | 2 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2000 | 4 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 575 | 0.010 |
Why?
|
| Organelles | 1 | 1998 | 6 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1998 | 54 | 0.010 |
Why?
|
| Lasers | 1 | 1998 | 67 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1998 | 133 | 0.010 |
Why?
|
| Cell Communication | 1 | 1998 | 66 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1990 | 36 | 0.010 |
Why?
|
| Reference Values | 1 | 1990 | 199 | 0.010 |
Why?
|